Overview
- 25 inspections across 21 sites are on record.
- 65 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-09.
At a glance
Inspections
25
Sites
21
Observations
65
Career since
Sep 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| SGS North America Inc. | 9 Jun 2026 | Human Drugs | View 483 → |
| Bentley Laboratories LLC | 27 Mar 2026 | Human Drugs | On file |
| New Life Pharma LLC | 13 Feb 2026 | Human Drugs | View 483 → |
| Health Pharma USA LLC | 18 Nov 2025 | Human Drugs | View 483 → |
| Molecular PharmaGroup LLC | 11 Aug 2025 | Human Drugs | View 483 → |
Sites inspected
SGS North America Inc.Fairfield, United States1 insp.
Bentley Laboratories LLCEdison, United States1 insp.
New Life Pharma LLCNorthvale, United States1 insp.
Health Pharma USA LLCRahway, United States1 insp.
Molecular PharmaGroup LLCNew Providence, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Suchan Kim6 shared
Annet R Rajan5 shared
JoshRenzo N Ramilo5 shared
John D Mcintosh5 shared
Josh Renzo N Ramilo5 shared
Janet A Rajan3 shared
Anthony J Donato3 shared
Jenny Sung3 shared
Jessica S Estriplet3 shared
Yaharn Su2 shared
Full investigator report
Get the verbatim findings behind Stephenie M Ortiz's 65 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site